Drug Manufacturers During the model pre-implementation period in early 2026, CMS negotiated with Novo Nordisk and Eli Lilly to come to agreement on the key parameters of the model, including details about pricing of the model drugs, cost sharing, rebate calculations, access policies (i.e., coverage criteria and prior authorization policies), the length of the agreement, data sharing arrangements, and agreement on lifestyle supports that will be offered
This article examines the evidence, explores safer alternatives such as metformin and insulin, and provides guidance on when to consult your GP about diabetes management during breastfeeding
Autism and lactic acidosis
Clinicians involved in the prescribing process were predominantly physicians, with MDs or DOs accounting for 28 of 49 websites (57.1%) and advanced practice registered nurses accounting for 17 (35.7%), while 4 websites (8.2%) offered no option to ask a clinician questions at all
Though there has been some rudimentary research work indicating that the GLP-1 receptor agonists can indirectly provide mood-enhancing effects by regulating the dopamine reward system, lessening inflammatory responses, or improving metabolic status, adverse events that have been observed in real life studies and case reports can suggest that their action at the central nervous system is more complicated [11, 16, 17]
In this insightful interview between Dr